Citigroup Inc Dynavax Technologies Corp Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Citigroup Inc holds 192,586 shares of DVAX stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

192,586

Previous 142,539 35.11%

Holding current value

$2.45 Million

Previous $1.6 Million 34.06%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.05 - $11.61 $502,972 - $581,045	50,047 Added 35.11%	192,586 $2.15 Million
Q2 2024 Aug 12, 2024	SELL	$10.73 - $12.58 $5.6 Million - $6.57 Million	-521,988 Reduced 78.55%	142,539 $1.6 Million
Q1 2024 May 10, 2024	BUY	$11.7 - $14.98 $2.24 Million - $2.87 Million	191,464 Added 40.47%	664,527 $8.25 Million
Q4 2023 Feb 09, 2024	BUY	$13.09 - $14.98 $2.86 Million - $3.27 Million	218,124 Added 85.56%	473,063 $6.61 Million
Q3 2023 Nov 09, 2023	BUY	$12.64 - $14.99 $603,825 - $716,087	47,771 Added 23.06%	254,939 $3.77 Million
Q2 2023 Aug 10, 2023	SELL	$9.85 - $13.17 $2.78 Million - $3.72 Million	-282,481 Reduced 57.69%	207,168 $2.68 Million
Q1 2023 May 11, 2023	BUY	$9.44 - $11.88 $1.2 Million - $1.51 Million	126,979 Added 35.01%	489,649 $4.8 Million
Q4 2022 Feb 09, 2023	SELL	$10.27 - $13.29 $2.43 Million - $3.15 Million	-236,734 Reduced 39.49%	362,670 $3.86 Million
Q3 2022 Nov 10, 2022	BUY	$9.93 - $17.44 $2.75 Million - $4.84 Million	277,357 Added 86.12%	599,404 $6.26 Million
Q2 2022 Aug 10, 2022	BUY	$7.45 - $12.83 $1.7 Million - $2.93 Million	228,377 Added 243.81%	322,047 $4.05 Million
Q1 2022 May 12, 2022	SELL	$9.75 - $14.44 $2.23 Million - $3.3 Million	-228,876 Reduced 70.96%	93,670 $1.02 Million
Q4 2021 Feb 10, 2022	SELL	$13.17 - $20.94 $947,160 - $1.51 Million	-71,918 Reduced 18.23%	322,546 $4.54 Million
Q3 2021 Nov 10, 2021	BUY	$9.16 - $19.83 $3.61 Million - $7.82 Million	394,464 New	394,464 $7.58 Million

Others Institutions Holding DVAX

# of Institutions

275

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.61B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account